Sugi Predict

Sugi Predict / Compounds / SCHEMBL6725006

SCHEMBL6725006

SCHEMBL6725006

c1ccc(-c2nc3c(-c4ccccc4)ccc(-c4ccccc4)c3nc2-c2ccc(N(c3ccccc3)c3ccccc3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 2/20 0.41
▸ PSMB5 P28074 1/20 0.40
▸ TDP1 Q9NUW8 5/20 0.39
▸ L3MBTL1 Q9Y468 5/20 0.39
▸ KDM4E B2RXH2 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ LMNA P02545 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ DHFR P00374 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ NOX1 Q9Y5S8 1/20 0.36
▸ HTT P42858 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12207335 1.00 ADK (0.41) ADKPSMB5TDP1L3MBTL1KDM4E
SCHEMBL12207690 1.00 ADK (0.41) ADKPSMB5TDP1L3MBTL1KDM4E
SCHEMBL12690592 0.98 ADK (0.40) ADKPSMB5TDP1L3MBTL1KDM4E
SCHEMBL6725072 0.98 ADK (0.40) ADKPSMB5TDP1L3MBTL1KDM4E
SCHEMBL12207336 0.98 ADK (0.40) ADKPSMB5TDP1L3MBTL1KDM4E
SCHEMBL12207692 0.98 ADK (0.40) ADKPSMB5TDP1L3MBTL1KDM4E
SCHEMBL6725793 0.98 ADK (0.40) ADKPSMB5TDP1L3MBTL1KDM4E
SCHEMBL6725054 0.98 ADK (0.40) ADKPSMB5TDP1L3MBTL1KDM4E
SCHEMBL14198224 0.98 ADK (0.40) ADKPSMB5TDP1L3MBTL1KDM4E
SCHEMBL6725288 0.94 ADK (0.38) ADKPSMB5TDP1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178216-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-15 — — US disclosed
US-8178216-B2 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-05-15 — — US disclosed
US-20090072718-A1 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-19 — — US disclosed
US-20090072718-A1 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090072718-A1 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative CRY1, GRK1, CRY2 ADK 2350/4885PSMB5 1281/4885TDP1 2515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.